Cymabay Therapeutics Inc

NASDAQ:CBAY   3:59:52 PM EDT
2.10
+0.20 (+10.53%)
Earnings Announcements

CymaBay Reports Q4 And Year Ended Dec 31, 2021 Results

Published: 03/17/2022 20:14 GMT
Cymabay Therapeutics Inc (CBAY) - Cymabay Reports Fourth Quarter and Year Ended December 31, 2021 Financial Results and Provides Corporate Update.
Cymabay Therapeutics Inc Qtrly Loss per Share $0.34.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.29

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.31

More details on our Analysts Page.